Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2025)

AVITA Medical (RCEL) has disclosed Income from Continuing Operations for 7 consecutive years, with 11621000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 123.15% year-over-year to 11621000.0, compared with a TTM value of 48587000.0 through Dec 2025, down 72417.91%, and an annual FY2025 reading of 48587000.0, down 72417.91% over the prior year.
  • Income from Continuing Operations was 11621000.0 for Q4 2025 at AVITA Medical, up from 13187000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 50189000.0 in Q4 2024 and bottomed at 18658000.0 in Q1 2024.
  • Average Income from Continuing Operations over 4 years is 1970875.0, with a median of 9691500.0 recorded in 2022.
  • Peak annual rise in Income from Continuing Operations hit 35.56% in 2025, while the deepest fall reached 123.15% in 2025.
  • Year by year, Income from Continuing Operations stood at 29227000.0 in 2022, then grew by 28.74% to 37626000.0 in 2023, then soared by 33.39% to 50189000.0 in 2024, then crashed by 123.15% to 11621000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for RCEL at 11621000.0 in Q4 2025, 13187000.0 in Q3 2025, and 9920000.0 in Q2 2025.